Zobrazeno 1 - 2
of 2
pro vyhledávání: '"José A. Broche"'
Autor:
Laura M. Rodríguez-Noda, David Goldblatt, María Eugenia Toledo-Romaní, Marisel Martínez, Yarmila García, Yury Valdés-Balbín, Marlene Armesto, Dagmar García-Rivera, Ada Rodríguez-Concepción, Alina Álvarez, Vladimir Echemendía, Nadezhda González, Vicente Verez-Bencomo, Darielys Santana Mederos, C. Ruiz, Amarilis Pérez, Nivaldo Linares-Pérez, Annaliet Iglesias, R. Gómez, María E. Mesa, José A. Broche, Beatriz Paredes Moreno, Yarisset Ricardo Delgado, Carlos Dotres Martínez, Pablo Cabrera, Nayibi Nuñez, Dania Vega, Rafael del Valle-Rodríguez, Mayelín Mirabal Sosa, Yanet Rodríguez
Publikováno v:
Vaccine. 36(32 Pt)
Background Cuba has a new pneumococcal conjugate vaccine candidate (PCV7-TT). This study evaluates the safety and immunogenicity in healthy infants using 2p+1 vaccination schedule. Methods A phase I, controlled, randomized and double blind clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f593f31b53f735a550e03974c1ad0d7
https://pubmed.ncbi.nlm.nih.gov/30005948
https://pubmed.ncbi.nlm.nih.gov/30005948
Autor:
Carlos P, Dotres, Rinaldo, Puga, Yariset, Ricardo, Carmen R, Broño, Beatriz, Paredes, Vladimir, Echemendía, Sandra, Rosell, Nadezhda, González, Dagmar, García-Rivera, Yury, Valdés, David, Goldblatt, Vicente, Vérez-Bencomo, José A, Broche
Publikováno v:
Vaccine. 32(41)
A new heptavalent conjugate vaccine (PCV7-TT) is under development in Cuba. PCV7-TT contains 2 μg of serotypes 1, 5, 14, 18C, 19F, 23F and 4 μg of 6B, each one conjugated to tetanus toxoid (TT). This vaccine was designed with the serotypes that cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa266c36d569720632b7e8cb2af2f2e
https://pubmed.ncbi.nlm.nih.gov/25068497
https://pubmed.ncbi.nlm.nih.gov/25068497